http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-730467-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B47-073
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B47-073
filingDate 1951-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d891f0d1e297aeec4715568ef1952d9
publicationDate 1955-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-730467-A
titleOfInvention New dyestuff intermediates
abstract Tetra - aza - porphin colouring - matters are manufactured by heating, in the presence or absence of metals, intermediates having in one tautomeric form the formula <FORM:0730467/IV (c)/1> or <FORM:0730467/IV (c)/2> wherein X represents an amino, alkyloxy, aralkyloxy or cycloalkyloxy group and wherein the alkyl, aralkyl or cycloalkyl radicals may carry substituents, R1 and R2 represent hydrogen or alkyl, aralkyl or cycloalkyl groups or jointly form with the 3 : 4-double bond of the pyrrole or isopyrrole nucleus a cyclohexene ring, R3 represents atoms which complete a heterocyclic ring, and n is a number greater than zero. In examples: (1) 2-imino-5-amino-3 : 4-tetrahydrobenzisopyrrole turns pink when heated to 110 DEG C. and progressively darkens on further heating; (2) 2-imino-5-amino-3 : 4-dimethylisopyrrole turns dark purple on heating above 135 DEG C.; (3) the hydrochloride of 2-imino - 5 - b - hydroxyethoxy - 3 : 4 - tetrahydrobenzisopyrrole (tautomeric with 2 : 2-ethylenedioxy - 5 - amino - 3 : 4 - tetrahydrobenzisopyrrole) is heated with triethylamine in o-dichlorobenzene to produce hexadecahydrophthalocyanine; (5) a compound of the first formula above in which X=CH3O and R1+R2=(CH2)4 is boiled in o-dichlorobenzene, or in n-propanol containing nickel acetate, yielding respectively hexadecahydrophthalocyanine and its nickel compound.ALSO:The invention comprises new dyestuff intermediates having in one tautomeric form the formula: <FORM:0730467/IV (b)/1> or <FORM:0730467/IV (b)/2> wherein X=amino, alkyloxy, aralkyloxy or cycloalkyloxy, and wherein the alkyl, aralkyl or cycloalkyl radicals may carry substituents (e.g. heterocyclic, alkyloxy, amino, substituted amino or hydroxyl groups or halogen atoms), R1 and R2=hydrogen or alkyl, aralkyl or cycloalkyl groups, which may carry substituents, or may be joined together to form with the 3 : 4 double bond of the pyrrole or isopyrrole nucleus a cyclohexene ring, R3 represents atoms which complete a heterocyclic ring, and n=a number greater than zero, and the manufacture thereof by the following processes: (a) when X=alkyloxy-, aralkyloxy-, or cycloalkyloxy-, by treating a maleic or fumaric dinitrile, which may carry one or two alkyl, aralkyl or cycloalkyl radicals, or a D 1-tetrahydrophthalonitrile, with a compound which contains a hydroxyl group attached to an alkyl, aralkyl or cycloalkyl radical, in the presence of an ancillary compound of the general formula R-O-R1 (wherein R is an alkali metal, one equivalent of an alkaline-earth metal (including magnesium), or an onium radical, and R1 is hydrogen or an organic radical; (b) when X=amino, by treating the appropriate dinitrile with ammonia, optionally in the presence of an ancillary substance as defined above. The products may be isolated in the form of salts, e.g. hydrochlorides, picrates or naphthalene mono-, di- or trisulphonates. Examples describe the preparation of: (1) 2-imino-5-amino-3 : 4-tetrahydrobenz-isopyrrole from D 1-tetrahydrophthalonitrile and ammonia in a solution of sodium in methanol; (2) 2-imino-5-amino-3 : 4-dimethylisopyrrole similarly from dimethylfumaric dinitrile; (3) 5-b -hydroxyethoxy-2-imino-3 : 4-tetrahydrobenz-isopyrrole or the tautomeric 2 : 2 - ethylenedioxy - 5 - amino - 3 : 4 - tetrahydrobenzisopyrrole from D 1 - tetrahydrophthalonitrile and a solution of sodium in ethylene glycol; (4) 5-b -hydroxyethoxy-2-imino - 3 : 4 - dimethylisopyrrole or the tautomeric 2 : 2 - ethylenedioxy - 5 - amino-3 - 4 - dimethyl - isopyrrole similarly from dimethylfumaric dinitrile; (5) a compound of the first formula above in which X=CH3O and R1+R2=(CH2)4, from D 1-tetrahydrophthalonitrile and methanolic caustic soda. Additional starting materials specified are: ethanol; dimethylmaleic dinitrile, citraconic dinitrile. Specification 698,049 is referred to. The Provisional Specification comprises also compounds of the first general formula above in which X represents a substituted amino group (obtainable by using an amine in place of ammonia in method (b) above) or an alkylmercapto, aralkylmercapto or cycloalkylmercapto group (obtainable by using a mercaptan in place of an alcohol in method (a) above), and the alcohol or mercaptan addition products and metal complexes of the various compounds, and describes an alternative method of preparing the compounds in which X is an amino or substituted amino group by treating a compound in which X is alkyloxy, aralkyloxy or cycloalkyloxy, or an alcohol addition product thereof, with ammonia or an amine (e.g. aniline, methylamine or ethylamine).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1197220-B
priorityDate 1951-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406948316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66584480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4432340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427755810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456412732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425199706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426033928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447567011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545

Total number of triples: 60.